Capricor Therapeutics CAPR
NASDAQ CAPR
$8.95 +0.01 (+0.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Return on Assets [ROA] (2011 - 2026)

Updated

Capricor Therapeutics (CAPR) posted Return on Assets [ROA] of -36.37% for Q2 2026, up 12.26 percentage points from -48.63% a year earlier but down 3.66 percentage points from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Capricor Therapeutics' Return on Assets [ROA] came in at -39.91%, down 4.60 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +19.82 percentage points (FY2020 to FY2025).
  • In prior years, Capricor Therapeutics' Return on Assets [ROA] was -35.31% in FY2024 (+5.76 pp), -41.07% in FY2023 (+22.75 pp), -63.82% in FY2022 (-8.84 pp) and -54.99% in FY2021 (+4.74 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -70.24% in Q3 2023 to a high of -30.64% in Q4 2024 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in six of the last eight quarters, with an average year-over-year change of +6.43 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2024, with a gain of 18.15 percentage points; the weakest was Q3 2023, with a drop of 20.50 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -32.70% (Q1 2026), -42.29% (Q4 2025) and -62.98% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Capricor Therapeutics 520.08 Mn 520.08 Mn - -36.37%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.37%
Mar 31, 2026 -32.70%
Dec 31, 2025 -42.29%
Sep 30, 2025 -62.98%
Jun 30, 2025 -48.63%
Mar 31, 2025 -33.90%
Dec 31, 2024 -30.64%
Sep 30, 2024 -52.09%
Jun 30, 2024 -63.86%
Mar 31, 2024 -45.06%
Dec 31, 2023 -46.62%
Sep 30, 2023 -70.24%
Jun 30, 2023 -58.46%
Mar 31, 2023 -56.03%
Dec 31, 2022 -56.09%
Sep 30, 2022 -49.74%
Jun 30, 2022 -41.92%
Mar 31, 2022 -44.32%
Dec 31, 2021 -49.46%
Sep 30, 2021 -45.03%
API Access

Capricor Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CAPR&period=max&api_key=YOUR_API_KEY